Cangen Biotechnologies is developing the next generation of early cancer diagnostics and designing chemo-sensitivity methods for the selection of optimal cancer therapies.
Cangen Biotechnologies, Inc.
300 East Lombard Street
Suite 1600
Baltimore, Maryland 21202
Mail to:
Suite 830
Temporary address until new facilities are completed at the Johns Hopkins BioPark